Novartis to sell parts of Sandoz to India ’s Aurobindo

Novartis has announced that it will sell its Sandoz U.S. dermatology business and generic U.S. oral solids portfolio to India ’s Aurobindo Pharma.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news